{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:40:41Z","timestamp":1761864041471,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["K-124813","NVKP_16-1-2016-0005","K-128785"],"award-info":[{"award-number":["K-124813","NVKP_16-1-2016-0005","K-128785"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The poor prognosis of head and neck squamous cell carcinoma (HNSCC) is partly due to the lack of reliable predictive markers. Connexin 43 (Cx43) protein and its cell-communication channels have been assigned tumor suppressor functions while the anti-apoptotic Bcl-2 (B-cell lymphoma-2) protein has been associated with negative prognostic significance in cancer. This study aimed to test the role of Cx43 protein on Bcl-2 expression, tumor progression and response to taxane-based treatment in HNSCC. Human papillomavirus (HPV) negative HNSCC cell lines were tested for paclitaxel sensitivity through measuring apoptosis induction, cell viability and changes in Cx43 and Bcl-2 levels using flow cytometry, cell viability assay, immunocytochemistry and western blot. Inhibition of Cx43 expression using siRNA increased Bcl-2 protein levels in SCC25 (tongue squamous cell carcinoma) cells, while forced Cx43 expression reduced Bcl-2 levels and supported paclitaxel cytotoxicity in FaDu (hypopharynx squamous cell carcinoma) cells. In vitro results were in line with protein expression and clinicopathological features tested in tissue microarray samples of HNSCC patients. Our data demonstrate that elevated Cx43 and reduced Bcl-2 levels may indicate HNSCC sensitivity to taxane-based treatments. On the contrary, silencing of the Cx43 gene GJA1 (gap junction protein alpha-1) can result in increased Bcl-2 expression and reduced paclitaxel efficiency. Clinical tumor-based analysis also confirmed the inverse correlation between Cx43 and Bcl-2 expression.<\/jats:p>","DOI":"10.3390\/cancers11121848","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T09:02:52Z","timestamp":1574413372000},"page":"1848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers\u2013In Vitro Studies"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-6255","authenticated-orcid":false,"given":"Bianka","family":"Gurbi","sequence":"first","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-282X","authenticated-orcid":false,"given":"Di\u00e1na","family":"Brauswetter","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1l","family":"Gyulav\u00e1ri","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga","family":"P\u00e9nzes","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5672-6482","authenticated-orcid":false,"given":"J\u00f3zsef","family":"Mur\u00e1nyi","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Z\u00e1mb\u00f3","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ede","family":"Birtalan","sequence":"additional","affiliation":[{"name":"Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Semmelweis University, H-1083 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Kren\u00e1cs","sequence":"additional","affiliation":[{"name":"Department of Pathology and Experimental Cancer Research, Semmelweis University, H-1085 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Laurence","family":"Becker","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-4361","authenticated-orcid":false,"given":"Mikl\u00f3s","family":"Csala","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"V\u00e1lyi-Nagy","sequence":"additional","affiliation":[{"name":"Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, H-1097 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Pet\u00e1k","sequence":"additional","affiliation":[{"name":"MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary"},{"name":"Oncompass Medicine Ltd, H-1024 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-8266","authenticated-orcid":false,"given":"Korn\u00e9l","family":"D\u00e1nos","sequence":"additional","affiliation":[{"name":"Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Semmelweis University, H-1083 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","first-page":"77","article-title":"Cetuximab: Its unique place in head and neck cancer treatment","volume":"7","author":"Specenier","year":"2013","journal-title":"Biol. Targets Therapy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/PAI.0000000000000590","article-title":"Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer","volume":"26","author":"Birtalan","year":"2018","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5306\/wjco.v5.i5.966","article-title":"Chemotherapy advances in locally advanced head and neck cancer","volume":"5","author":"Georges","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"ref_9","first-page":"S3","article-title":"Taxol (paclitaxel): Mechanisms of action","volume":"5","author":"Horwitz","year":"1994","journal-title":"Annals Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_10","first-page":"378","article-title":"Predictive biomarkers for combined chemotherapy with 5-fluorouracil and cisplatin in oro- and hypopharyngeal cancers","volume":"8","author":"Hasegawa","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3892\/etm.2017.4589","article-title":"Connexin 43 enhances paclitaxel cytotoxicity in colorectal cancer cell lines","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1165>3.0.CO;2-G","article-title":"Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells","volume":"92","author":"Huang","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cardiores.2003.11.013","article-title":"Gap junctions and the connexin protein family","volume":"62","author":"Sohl","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PAI.0000000000000212","article-title":"The Potential Prognostic Value of Connexin 43 Expression in Head and Neck Squamous Cell Carcinomas","volume":"24","author":"Danos","year":"2016","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Teleki, I., Szasz, A.M., Maros, M.E., Gyorffy, B., Kulka, J., Meggyeshazi, N., Kiszner, G., Balla, P., Samu, A., and Krenacs, T. (2014). Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112541"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"a008722","DOI":"10.1101\/cshperspect.a008722","article-title":"Multiple functions of BCL-2 family proteins","volume":"5","author":"Hardwick","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00005537-200204000-00009","article-title":"Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: Correlation with response to chemotherapy and organ preservation","volume":"112","author":"Trask","year":"2002","journal-title":"Laryngoscope"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1593\/neo.07394","article-title":"Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells","volume":"9","author":"Li","year":"2007","journal-title":"Neoplasia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrc2841","article-title":"Implications and challenges of connexin connections to cancer","volume":"10","author":"Naus","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.febslet.2014.01.001","article-title":"Gap junction and hemichannel-independent actions of connexins on cell and tissue functions\u2014An update","volume":"588","author":"Zhou","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12929-019-0497-x","article-title":"Emerging roles of gap junction proteins connexins in cancer metastasis, chemoresistance and clinical application","volume":"26","author":"Wu","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbamem.2005.11.004","article-title":"Defective gap junctional intercellular communication in the carcinogenic process","volume":"1719","author":"Mesnil","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12105-016-0685-x","article-title":"Connexin 43 (Cx43) Expression in Laryngeal Squamous Cell Carcinomas: Preliminary Data on Its Possible Prognostic Role","volume":"10","author":"Puzzo","year":"2016","journal-title":"Head Neck Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/ijo.2014.2394","article-title":"Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma","volume":"45","author":"Brockmeyer","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/mco.2016.828","article-title":"Connexin 43 expression is associated with poor survival in patients with esophageal squamous cell carcinoma","volume":"4","author":"Tanaka","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Aasen, T., Sansano, I., Montero, M.A., Romagosa, C., Temprana-Salvador, J., Martinez-Marti, A., Moline, T., Hernandez-Losa, J., and Ramon y Cajal, S. (2019). Insight into the Role and Regulation of Gap Junction Genes in Lung Cancer and Identification of Nuclear Cx43 as a Putative Biomarker of Poor Prognosis. Cancers, 11.","DOI":"10.20944\/preprints201902.0109.v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1038\/sj.onc.1205630","article-title":"Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancer","volume":"21","author":"Dubina","year":"2002","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/19.11.1889","article-title":"Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43","volume":"19","author":"Zhang","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1520-6408(1999)24:1\/2<91::AID-DVG10>3.0.CO;2-#","article-title":"Suppression of human prostate cancer cell growth by forced expression of connexin genes","volume":"24","author":"Mehta","year":"1999","journal-title":"Dev. Genet."},{"key":"ref_31","first-page":"861","article-title":"Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential","volume":"7","author":"Hirschi","year":"1996","journal-title":"Cell Growth Differ.-Publ. Am. Assoc. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/exmp.2002.2436","article-title":"Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43","volume":"73","author":"Fernstrom","year":"2002","journal-title":"Exp. Mol. Pathol."},{"key":"ref_33","first-page":"225","article-title":"Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice","volume":"30","author":"Fukushima","year":"2007","journal-title":"Int. J. Oncol."},{"key":"ref_34","first-page":"5089","article-title":"Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43)","volume":"58","author":"Huang","year":"1998","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.onc.1204563","article-title":"Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27","volume":"20","author":"Zhang","year":"2001","journal-title":"Oncogene"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0960-9822(01)00424-9","article-title":"Gap junction protein connexin-43 interacts directly with microtubules","volume":"11","author":"Giepmans","year":"2001","journal-title":"Curr. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Varga, A., Gyulavari, P., Greff, Z., Futosi, K., Nemeth, T., Simon-Szabo, L., Kerekes, K., Szantai-Kis, C., Brauswetter, D., and Kokas, M. (2015). Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124234"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.yexcr.2007.01.012","article-title":"Myoblast proliferation and syncytial fusion both depend on connexin43 function in transfected skeletal muscle primary cultures","volume":"313","author":"Gorbe","year":"2007","journal-title":"Exp. Cell Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0360-3016(00)01498-X","article-title":"bcl-2 expression in head and neck cancer: An enigmatic prognostic marker","volume":"49","author":"Wilson","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_41","first-page":"261","article-title":"bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy","volume":"2","author":"Gallo","year":"1996","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:45Z","timestamp":1760189805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cancers11121848"],"URL":"https:\/\/doi.org\/10.3390\/cancers11121848","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2019,11,22]]}}}